| D-0850-2026 | Class I | Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 6 | August 17, 2026 |
| D-0849-2026 | Class I | 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxte | August 17, 2026 |
| Z-3066-2026 | Class II | Baxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSL | August 11, 2026 |
| Z-3065-2026 | Class II | Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS | August 11, 2026 |
| D-0806-2026 | Class II | MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, B | August 6, 2026 |
| D-0811-2026 | Class II | Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dos | August 6, 2026 |
| D-0812-2026 | Class II | Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion | August 6, 2026 |
| D-0815-2026 | Class II | Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Co | August 6, 2026 |
| D-0819-2026 | Class II | Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dos | August 6, 2026 |
| D-0807-2026 | Class II | Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL S | August 6, 2026 |
| D-0805-2026 | Class II | Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, | August 6, 2026 |
| D-0808-2026 | Class II | Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Co | August 6, 2026 |
| D-0817-2026 | Class II | Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Conta | August 6, 2026 |
| D-0809-2026 | Class II | Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx | August 6, 2026 |
| D-0818-2026 | Class II | Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Conta | August 6, 2026 |
| D-0816-2026 | Class II | Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-D | August 6, 2026 |
| D-0821-2026 | Class II | Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 10 | August 6, 2026 |
| D-0820-2026 | Class II | Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Co | August 6, 2026 |
| D-0814-2026 | Class II | Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonp | August 6, 2026 |
| D-0813-2026 | Class II | CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/m | August 6, 2026 |